BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2458325)

  • 1. Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.
    Weller M; Heimann K; Wiedemann P
    Int Ophthalmol; 1988 Jan; 11(3):181-6. PubMed ID: 2458325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal anti-human macrophage antibody.
    Weller M; Heimann K; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):252-4. PubMed ID: 3402749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
    Weller M; Heimann K; Wiedemann P
    Med Hypotheses; 1990 Feb; 31(2):157-9. PubMed ID: 2325589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M; Heimann K; Wiedemann P
    Fortschr Ophthalmol; 1989; 86(2):121-3. PubMed ID: 2661370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy.
    Baudouin C; Fredj-Reygrobellet D; Gordon WC; Baudouin F; Peyman G; Lapalus P; Gastaud P; Bazan NG
    Am J Ophthalmol; 1990 Dec; 110(6):593-8. PubMed ID: 1701071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of macrophages and fibronectin in vitreoretinal proliferation].
    Weller M; Heimann K; Wiedemann P
    J Fr Ophtalmol; 1988; 11(3):243-7. PubMed ID: 3047202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and lymphocytes in proliferative vitreoretinopathy.
    Proença R; Carvalho M; Proença D; Verissimo J; Regadas I; Travassos A
    Graefes Arch Clin Exp Ophthalmol; 1994 Jan; 232(1):25-32. PubMed ID: 8119598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of traumatic proliferative vitreoretinopathy].
    Xu H
    Yan Ke Xue Bao; 1992 Jun; 8(2):80-2. PubMed ID: 1299605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M; Esser P; Wiedemann P; Heimann K
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI; Chung H; Lee J
    Korean J Ophthalmol; 1991 Dec; 5(2):68-75. PubMed ID: 1812289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.
    Weller M; Wiedemann P; Bresgen M; Heimann K
    Int Ophthalmol; 1991 Mar; 15(2):93-101. PubMed ID: 1708748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mononuclear phagocytes in proliferative vitreoretinopathy (PVR). A specific role of microglial cells in non-traumatic disease?
    Weller M; Esser P; Heimann K; Wiedemann P
    Eur J Ophthalmol; 1991; 1(4):161-6. PubMed ID: 1821209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of fibronectin in vitreoretinal pathology. A critical evaluation.
    Weller M; Wiedemann P; Heimann K; Zilles K
    Graefes Arch Clin Exp Ophthalmol; 1988; 226(3):294-8. PubMed ID: 3402754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of epidermal growth factor receptor in a human epiretinal membrane.
    Heidenkummer HP; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):492-6. PubMed ID: 1718825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study.
    Tang S; Scheiffarth OF; Wildner G; Thurau SR; Lund OE
    Ger J Ophthalmol; 1992; 1(3-4):176-9. PubMed ID: 1483132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages in human epiretinal and vitreal membranes in patients with proliferative intraocular disorders.
    Tang S; Gao R; Wu DZ
    Yan Ke Xue Bao; 1996 Mar; 12(1):28-32. PubMed ID: 9275733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens.
    Limb GA; Franks WA; Munasinghe KR; Chignell AH; Dumonde DC
    Graefes Arch Clin Exp Ophthalmol; 1993 Jun; 231(6):331-6. PubMed ID: 8339948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathology of the vitreoretinal interface].
    Sahel J
    J Fr Ophtalmol; 1985; 8(4):353-69. PubMed ID: 4020045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.